Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma

References

• 1 Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352(10), 987–996 (2005).
  Medline CASGoogle Scholar
• 2 The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216), 1061–1068 (2008).
  MedlineGoogle Scholar
• 3 Noushmehr H, Weisenberger DJ, Diefes K et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5), 510–522 (2010).
  Medline CASGoogle Scholar
• 4 Peereboom DM, Shepard DR, Ahluwalia MS et al. Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. J. Neurooncol. 98(1), 93–99 (2010).
  Medline CASGoogle Scholar
• 5 Sottoriva A, Spiteri I, Piccirillo SG et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad. Sci. USA 110(10), 4009–4014 (2013).
  Medline CASGoogle Scholar
• 6 Szerlip NJ, Pedraza A, Chakravarty D et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc. Natl Acad. Sci. USA 109(8), 3041–3046 (2012).
  Medline CASGoogle Scholar
• 7 Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia 60(3), 502–514 (2012).
  MedlineGoogle Scholar
• 8 Hussain SF, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro. Oncol. 8(3), 261–279 (2006).
  Medline CASGoogle Scholar
• 9 Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 216(1), 15–24 (2008).
  Medline CASGoogle Scholar
• 10 Engler JR, Robinson AE, Smirnov I et al. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. PLoS ONE 7(8), e43339 (2012).
  Medline CASGoogle Scholar
• 11 Pyonteck SM, Akkari L, Schuhmacher AJ et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19(10), 1264–1272 (2013).
  Medline CASGoogle Scholar
• 12 Qian BZ, Pollard JW: Macrophage diversity enhances tumor progression and metastasis. Cell 141(1), 39–51 (2010).
  Medline CASGoogle Scholar
• 13 Parney IF, Waldron JS, Parsa AT. Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. J. Neurosurg. 110(3), 572–582 (2009).
  Medline CASGoogle Scholar
• 14 Du R, Lu KV, Petritsch C et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13(3), 206–220 (2008).
  Medline CASGoogle Scholar
• 15 De Palma M, Mazzieri R, Politi LS et al. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell 14(4), 299–311 (2008).
  Medline CASGoogle Scholar
• 16 Zhu X, Fujita M, Snyder LA, Okada H. Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy. J. Neurooncol. 104(1), 83–92 (2011).
  Medline CASGoogle Scholar
• 17 Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J. Clin. Invest. 120(3), 694–705 (2010).
  Medline CASGoogle Scholar
• 18 Liu SC, Alomran R, Chernikova SB et al. Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats. Neuro. Oncol. 16(1), 21–28 (2014).
  Medline CASGoogle Scholar
• 19 DeNardo DG, Brennan DJ, Rexhepaj E et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 1(1), 54–67 (2011).
  Medline CASGoogle Scholar
• 20 Coniglio SJ, Eugenin E, Dobrenis K et al. Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol. Med. 18, 519–527 (2012).
  Medline CASGoogle Scholar
• 21 Wang T, Papoutsi M, Wiesmann M et al. Investigation of correlation among safety biomarkers in serum, histopathological examination, and toxicogenomics. Int. J. Toxicol. 30(3), 300–312 (2011).
  Medline CASGoogle Scholar
• 22 Radi ZA, Koza-Taylor PH, Bell RR et al. Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury. Am. J. Pathol. 179(1), 240–247 (2011).
  MedlineGoogle Scholar
• 23 Ahn GO, Brown JM. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13(3), 193–205 (2008).
  Medline CASGoogle Scholar
• 24 Agarwalla P, Barnard Z, Fecci P, Dranoff G, Curry WT Jr. Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors. J. Immunother. 35(5), 385–389 (2012).
  Medline CASGoogle Scholar